Home
October 2008 November 2008 December 2008
Su Mo Tu We Th Fr Sa
Week 44 1
Week 45 2 3 4 5 6 7 8
Week 46 9 10 11 12 13 14 15
Week 47 16 17 18 19 20 21 22
Week 48 23 24 25 26 27 28 29
Week 49 30

SUFU 2007 - Impact of Overactive Bladder and Incontinence on Mental Health and Health-Related Quality of Life in Women Show Comments PDF Print E-mail
  
Thursday, 01 March 2007

Debra E. Irwin, 1 Ian Milsom, 2 Con J. Kelleher, 3 Zoe Kopp 4

1University of North Carolina, Chapel Hill, NC, USA; 2Sahlgrenska Academy at Göteborg University, Göteborg, Sweden; 3St. Thomas’ Hospital, London, UK; 4Pfizer Inc, New York, NY, USA

Introduction and Objectives: We evaluated depressive symptoms, health-related quality of life (HRQL), and bladder condition severity in women with overactive bladder (OAB), with or without urinary incontinence (UI), and in women with stress UI (SUI).

Methods: A population-based survey of adults was conducted in 5 countries. Computer-assisted telephone interviews were conducted with a geographically stratified random sample of the population (N=19,165). OAB and subtypes of UI, including mixed (MUI), urgency (UUI), and SUI, were defined per 2002 International Continence Society (ICS) definitions. Cases were individuals with OAB and/or SUI symptoms; controls were frequency matched by age, gender, and country from individuals without OAB or SUI symptoms. Cases and controls were asked in-depth questions about HRQL and depressive symptoms. The EuroQoL (EQ-5D) measured overall HRQL (range of weighted utility scores, 0–1); Patient Perception of Bladder Condition (PPBC) assessed severity of bladder condition; and the Center for Epidemiologic Studies–Depression (CES-D) scale measured depressive symptoms (score range, 0–60). Lower EQ-5D scores indicated poorer HRQL, individuals reporting that their bladder condition caused at least minor problems were considered bothered, and a CES-D score 21 indicated major depressive symptoms.

Results: Results are summarized in the Table:

Women

EQ-5D

(Mean)

PPBC

(% Bothered)

CES-D
(%
21)

Controls (n=932)

0.89

NA

4.6

OAB without UI (n=415)*

0.85

22.9

9.4

OAB with UI (n=507)*

0.81

50.2

15.7

UUI only (n=136)

0.83

46.0

13.0

MUI (n=209)

0.80

60.1

17.0

OAB with SUI only (n=131)

0.80

43.6

15.5

OAB with Other UI (n=31)

0.78

29.0

20.7

SUI only (no OAB) (n=532)

0.87

23.0

10.4

NA=not applicable, controls were not asked PPBC.

* Unable to determine continence status for 10 OAB cases; P≤0.05 versus controls; P≤0.05 versus OAB without UI.

Conclusions: This was the first multinational, population-based study to measure generic HRQL, symptom bother, and depressive symptoms using validated questionnaires and current ICS definitions. Women with OAB reported poorer HRQL and more depressive symptoms compared to controls. Diminished HRQL, increased symptom bother, and more depressive symptoms were most pronounced among patients with OAB and UI. Women with SUI without OAB reported less impact than those with OAB and any type of UI.

UroToday.com Coverage of SUFU 2007

Reader Comments

Please log-in or register in order to submit comments.

Powered by AkoComment!

 
User Rating: / 0
PoorBest


 
< Prev   Next >